We presented the Genotype Imputed Gene Set Enrichment Analysis (GIGSEA), a novel method that uses GWAS-and-eQTL-imputed differential gene expression to interrogate gene set enrichment for the trait-associated SNPs. By incorporating eQTL from large gene expression studies, e.g. GTEx, GIGSEA appropriately addresses such challenges for SNP enrichment as gene size, gene boundary, andmultiple-marker regulation. The weighted linear regression model, taking as weights both imputation accuracy and model completeness, was used to test the enrichment, properly adjusting the bias due to redundancy in different gene sets. The permutation test, furthermore, is used to evaluate the significance of enrichment, whose efficiency can be largely elevated by expressing the computational intensive part in terms of large matrix operation. We have shown the appropriate type I error rates for GIGSEA (<5%), and the preliminary results also demonstrate its good performance to uncover the real biological signal.
In GIGSEA, the gene sets are saved as matrices. Such matrices are largely sparse, so, in order to save space, we used the functions provided by the R package “Matrix” to build the sparse matrices and pre-saved into the GIGSEA package. In addition, GIGSEA uses the local fdr, implemented by the R package “locfdr”, to adjust for multiple hypothesis testing.
## Loading required package: Matrix## Loading required package: MASS## Loading required package: locfdrGIGSEA first uses MetaXcan (also called “s-predixcan”) to impute
trait-associated differential gene expression from both GWAS summary and
eQTL database with LD structure adjusted, and next, builds a weighted
regression model to perfrom gene set enrichment analysis. In user’s
convenience, we combine these procedures together into one function
runGIGSEA(), which writes the enrichment test results at
the local directory. Users only need to provide their GWAS summary data,
and specify the paths to the MetaXcan.py file, the eQTL database
(e.g. GTex and DGN) and the reference popultation (e.g. 1000
Genome).
# runGIGSEA( MetaXcan="software/MetaXcan.py" ,
# model_db_path="eQTL/DGN-WB_0.5.db",
# covariance="reference/covariance.DGN-WB_0.5.txt.gz",
# gwas_folder="data/GWAS_summary", gwas_file_pattern="heart.sumstats",
# output_dir="result/GIGSEA", permutation_num=1000)Alternatively, users can also submit their GWAS summary data to the online version of MetaXcan (s-predixcan) https://cloud.hakyimlab.org/s-predixcan to impute the trait-associated differential gene expression, and next, run the following steps provided by GIGSEA to perform the gene set enrichment analysis for the trait-associated SNPs.
***In case that users had neither installed MetaXcan nor run the online MetaXcan, an example of MetaXcan-imputed differential gene expression is given as follows. Users can use it to test the codes of GIGSEA step by step.
MetaXcan integrates GWAS summary result with eQTL information to map trait-associated genes. See https://github.com/hakyimlab/MetaXcan. It provides a novel way to aggregate the multiple markers within each gene, address the long-range regulation, and adjust bias from gene boundaries and gene size. We use MetaXcan to impute the complex-trait-associated differential gene expression from eQTL summary and GWAS summary datasets. MetaXcan imputes ~10,000 genes with high quality prediction in most tissues. The training dataset for the expression prediction or 1000 Genomes was used as reference population to address the LD structure (covariance) of markers. Users can also specify their own genotype data to address the LD structure. The eQTL summary data was pre-calculated from large gene expression studies, such as the Genotype-Tissue Expression Project (GTEx; a comprehensive set of tissues from of ~20,000 samples) (Lonsdale, et al., 2013) and Depression Genes and Networks (DGN; 922 whole-blood samples) (Battle, et al., 2014). So, users only need to provide the GWAS summary data to estimate the genetically regulated gene expression.
We take as an example the cardiovascular disease (CVD) GWAS, CARDIoGRAMplusC4D (60,801 cases, 123,504 controls and 9.4M SNPs) (Nikpay, et al., 2015). The summary data is downloaded from <www.cardiogramplusc4d.org/data-downloads/>. We run the MetaXcan on it based on DGN eQTL database and 1000 Genomes as covariance.
## gene gene_name zscore effect_size pvalue var_g
## 1 ENSG00000134222 PSRC1 -8.857086 -0.13668948 8.213281e-19 0.1981241807
## 2 ENSG00000107798 LIPA 6.946756 0.08913688 3.737808e-12 0.2702763074
## 3 ENSG00000135148 TRAFD1 6.104691 2.80669383 1.030000e-09 0.0002579440
## 4 ENSG00000111249 CUX2 -6.074906 -2.76985557 1.240602e-09 0.0002799391
## 5 ENSG00000186063 AIDA 5.997636 0.37241430 2.002105e-09 0.0129998359
## 6 ENSG00000115486 GGCX 5.806570 0.06182678 6.376555e-09 0.4009731992
## pred_perf_r2 pred_perf_pval pred_perf_qval n_snps_used n_snps_in_cov
## 1 0.251784300 5.893333e-60 4.019735e-59 11 11
## 2 0.608481823 1.560951e-189 6.547543e-188 8 8
## 3 0.003758508 6.277686e-02 8.269168e-02 1 1
## 4 0.005794522 2.079893e-02 2.853868e-02 2 2
## 5 0.020511033 1.269367e-05 2.143166e-05 11 11
## 6 0.459503100 4.710932e-125 8.726820e-124 24 24
## n_snps_in_model
## 1 11
## 2 9
## 3 1
## 4 2
## 5 11
## 6 25Each row is a gene’s association result:
gene: a gene’s idgene_name: a gene’s namezscore: MetaXcan’s association result for the geneeffect_size: MetaXcan’s association effect size for the
genepvalue: P-value of the aforementioned statisticpred_perf_r2: R2 of transcriptome prediction model’s
correlation to gene’s measured transcriptomepred_perf_pval: pval of transcriptome prediction
model’s correlation to gene’s measured transcriptomepred_perf_qval: qval of transcriptome prediction
model’s correlation to gene’s measured transcriptomen_snps_used: number of snps from GWAS that got used in
MetaXcan analysisn_snps_in_cov: number of snps in the covariance
matrixn_snps_in_model: number of snps in the prediction
modelvar_g: variance of the gene expressionWe use the linear regression model to build a threshold-free gene set enrichment test, checking whether genes are significantly differentially expressed in a given gene set, as compared to the background. In the regression model, we regress the imputed Z-score of differential gene expression on the gene sets. However, the gene expression cannot be perfectly predicted using genotype, which is indicated by the prediction R^2, and moreover, not all SNPs in the prediction model are in user’s dataset. In order to take into account such two factors, we use as weights the multiplication of prediction R^2 and fraction of imputation-used SNPs, building a weighted linear regression model.
gene = heart.metaXcan$gene_name
# extract the imputed Z-score of differential gene expression, which follows
# the normal distribution
fc <- heart.metaXcan$zscore
# use the prediction R^2 and fraction of imputation-used SNPs as weights
usedFrac <- heart.metaXcan$n_snps_used / heart.metaXcan$n_snps_in_model
r2 <- heart.metaXcan$pred_perf_r2
weights <- usedFrac*r2
# build a new data frame for the following weighted linear regression-based
# enrichment analysis
data <- data.frame(gene,fc,weights)
head(data)## gene fc weights
## 1 PSRC1 -8.857086 0.251784300
## 2 LIPA 6.946756 0.540872732
## 3 TRAFD1 6.104691 0.003758508
## 4 CUX2 -6.074906 0.005794522
## 5 AIDA 5.997636 0.020511033
## 6 GGCX 5.806570 0.441122976GIGSEA is built on the weighted linear regression model, so it permits both discrete-valued and continuous-valued gene sets. We already incorporated several gene sets into the GIGSEA package, including:
MSigDB.KEGG.Pathway: Gene sets derived from the KEGG
pathway database. It comprises 186 pathways (column) and 5267 genes
(row). See c2.cp.kegg.v6.0.symbols.gmt.txt at http://software.broadinstitute.org/gsea/msigdb/collections.jsp#C2MSigDB.TF: Gene sets that share upstream cis-regulatory
motifs which can function as potential transcription factor binding
sites. It comprises 615 TFs (column) and 12774 genes (row). See
c3.tft.v6.0.symbols.gmt.txt at http://software.broadinstitute.org/gsea/msigdb/collections.jsp#C3MSigDB.miRNA: Gene sets that contain genes sharing
putative target sites (seed matches) of human mature miRNA in their
3’-UTRs. It comprises 221 miRNAs (column) and 7444 genes (row). See
c3.mir.v6.0.symbols.gmt.txt at http://software.broadinstitute.org/gsea/msigdb/collections.jsp#C3GO: Gene sets that contain genes annotated by the same
Gene Ontology (GO) term. For each GO term, we not only incorporate its
own gene sets, but also incorporate the gene sets belonging to its
offsprings. See the “database GO.db” in R.Fantom5.TF: The human transcript promoter locations
were obtained from Fantom5. Based on the promoter locations, the tool
MotEvo was used to predict the human transcriptional factor (TF) target
sites. The dataset contains 500 Positional Weight Matrices (PWM) and
21964 genes. For each PWM, there is a list of associated human TFs,
ordered by percent identity of TFs known to bind sites of the PWM. The
list of associations was checked manually. The entire set of PWMs and
mapping to associated TFs is available from the SwissRegulon website http://www.swissregulon.unibas.ch.TargetScan.miRNA: Gene sets of predicted human miRNA
target sites were downloaded from TargetScan. TargetScan groups miRNAs
that have identical subsequences at positions 2 through 8 of the miRNA,
i.e. the 2-7 seed region plus the 8th nucleotide, and provides
predictions for each such seed motif. TargetScan covers 87 human miRNA
seed motifs in total. It provides a score for each seed motif and each
RefSeq transcript, called preferential conservation scoring (aggregate
Pct), which shows consistently high performance in various benchmark
tests. To obtain a site count associated with each gene, we average the
TargetScan Pct scores of all RefSeq transcripts associated with each
gene. It comprises 87 miRNA seed motifs and 9861 genes. See http://www.targetscan.org.LINCS.CMap.drug: Large perturbational datasets of gene
expression signature from small-molecule compounds in multiple cell
types from LINCS/CMap database. We downloaded the data of LINCS phase 2
level 5 from GEO (GSE70138). The data is saved in the GCTx format
(binary format based on HDF5 that enables fast i/o than text), and we
parsed it using the R package cmapR. The LINCS level 5 data is a numeric
matrix, comprising 118050 drugs/doses and 12328 genes. Each entry is a
replicate-collapsed z-score of differential gene expression due to a
drug perturbation, which is calculated by aggregating across individual
replicates. See https://clue.io. In order to generate a single signature
for each drug perturbation, we further average the differential gene
expression across different drug doses, resulting in a condensed matrix
of 1826 drugs (column) and 12328 genes (row).We first show an example of discrete-valued gene set: MSigDB.KEGG.Pathway, where the row represents the gene, and the column represents the pathway. Each entry takes discrete values of 0 or 1, where 1 represents the gene (row) belongs to the pathway (column), and otherwise, not.
# load data
data(MSigDB.KEGG.Pathway)
# MSigDB.KEGG.Pathway is a list comprising two components: net and annot
class(MSigDB.KEGG.Pathway)## [1] "list"## [1] "net" "annot"## [1] 5267 186## [1] "KEGG_GLYCOLYSIS_GLUCONEOGENESIS"
## [2] "KEGG_CITRATE_CYCLE_TCA_CYCLE"
## [3] "KEGG_PENTOSE_PHOSPHATE_PATHWAY"
## [4] "KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS"
## [5] "KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM"
## [6] "KEGG_GALACTOSE_METABOLISM"## [1] "A2M" "A4GALT" "AACS" "AADAT" "AANAT" "AARS"## term
## 1 KEGG_GLYCOLYSIS_GLUCONEOGENESIS
## 2 KEGG_CITRATE_CYCLE_TCA_CYCLE
## 3 KEGG_PENTOSE_PHOSPHATE_PATHWAY
## 4 KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS
## 5 KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM
## 6 KEGG_GALACTOSE_METABOLISM
## link
## 1 http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCOLYSIS_GLUCONEOGENESIS
## 2 http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_CITRATE_CYCLE_TCA_CYCLE
## 3 http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PENTOSE_PHOSPHATE_PATHWAY
## 4 http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS
## 5 http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM
## 6 http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GALACTOSE_METABOLISM
## totalGenes
## 1 62
## 2 32
## 3 27
## 4 28
## 5 34
## 6 26## 6 x 30 sparse Matrix of class "dgCMatrix"## [[ suppressing 30 column names 'KEGG_GLYCOLYSIS_GLUCONEOGENESIS', 'KEGG_CITRATE_CYCLE_TCA_CYCLE', 'KEGG_PENTOSE_PHOSPHATE_PATHWAY' ... ]]##
## A2M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
## A4GALT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
## AACS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
## AADAT . . . . . . . . . . . . . . . . . . . 1 . . . . 1 . . . . .
## AANAT . . . . . . . . . . . . . . . . . . . . . . . . 1 . . . . .
## AARS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Followed is an example of continuous-valued gene set: TargetScan.miRNA, where the row represents the gene, and the column represents the miRNA. Each entry takes continuous values of pct, representing the binding affinity of miRNA on the gene 3’ UTR.
# load data
data(TargetScan.miRNA)
# TargetScan.miRNA is a list comprising two components: net and annot
class(TargetScan.miRNA)## [1] "list"## [1] "net" "annot"## [1] 9861 87## [1] "hsa-let-7a hsa-let-7b hsa-let-7c hsa-let-7d hsa-let-7e hsa-let-7f hsa-miR-98 hsa-let-7g hsa-let-7i hsa-miR-4458 hsa-miR-4500"
## [2] "hsa-miR-1 hsa-miR-206 hsa-miR-613"
## [3] "hsa-miR-101"
## [4] "hsa-miR-103a hsa-miR-107"
## [5] "hsa-miR-10a hsa-miR-10b"
## [6] "hsa-miR-122"## [1] "A1CF" "A2LD1" "AAGAB" "AAK1" "AAMP" "AARS"## mirna
## 49 hsa-let-7a hsa-let-7b hsa-let-7c hsa-let-7d hsa-let-7e hsa-let-7f hsa-miR-98 hsa-let-7g hsa-let-7i hsa-miR-4458 hsa-miR-4500
## 57 hsa-miR-1 hsa-miR-206 hsa-miR-613
## 14 hsa-miR-101
## 53 hsa-miR-103a hsa-miR-107
## 18 hsa-miR-10a hsa-miR-10b
## 59 hsa-miR-122
## family totalGenes
## 49 GAGGUAG 1046
## 57 GGAAUGU 769
## 14 ACAGUAC 788
## 53 GCAGCAU 638
## 18 ACCCUGU 216
## 59 GGAGUGU 112## 6 x 20 sparse Matrix of class "dgCMatrix"## [[ suppressing 20 column names 'hsa-let-7a hsa-let-7b hsa-let-7c hsa-let-7d hsa-let-7e hsa-let-7f hsa-miR-98 hsa-let-7g hsa-let-7i hsa-miR-4458 hsa-miR-4500', 'hsa-miR-1 hsa-miR-206 hsa-miR-613', 'hsa-miR-101' ... ]]##
## A1CF 0.000 . . . . . . . . . 0.331 . . . . . . . . .
## A2LD1 . . . . . . . . . . . . . . . . . . . .
## AAGAB . . . . . . . . . . . . . . . . . . . .
## AAK1 0.922 . . . 0.581 0 0.836 . . . . 0.951 0.879 . . . 0.376 . . .
## AAMP . . . . . . . . . . . . . . . . . . . .
## AARS . . . . . . . . . . . . . . . . . . . .In adition to the above predefined gene sets, users can also specify their own gene set. Here, we take as an example the CREEDS <amp.pharm.mssm.edu/CREEDS/>. It is a manually curated database of gene signatures of single drug perturbations. For each drug perturbation, it lists both up-regulated and down-regulated gene sets. In the following example, we transform the gmt format file into a sparse matrix, where for each drug perturbation, the up-regulated genes take the value of 1, the down-regulated genes take the value of -1, and the others take the value of 0.
# downlaod the gmt file
gmt <- readLines( paste0('http://amp.pharm.mssm.edu/CREEDS/download/',
'single_drug_perturbations-v1.0.gmt') )
# obtain the index of up-regulated and down-regulated gene sets
index_up <- grep('-up',gmt)
index_down <- grep('-dn',gmt)
# transform the gmt file into gene sets. The gene set is a data frame,
# comprising three vectors: term (here is drug), geneset (a gene symbol list
# separated by comma), and value (1 and -1 separated by comma)
gff_up <- gmt2geneSet( gmt[index_up] , termCol=c(1,2) , singleValue = 1 )
gff_down <- gmt2geneSet( gmt[index_down] , termCol=c(1,2) , singleValue = -1 )
# as following, combine the up and down-regulated gene sets together,
# and use value of 1 and -1 to indicate their direction:
# extract the drug names
term_up <- sapply( gff_up$term , function(x) gsub('-up','',x) )
term_down <- sapply( gff_down$term , function(x) gsub('-dn','',x) )
all(term_up==term_down)## [1] TRUE# combine up and down-regulated gene names for each drug perturbation
geneset <- sapply( 1:nrow(gff_up) , function(i)
paste(gff_up$geneset[i],gff_down$geneset[i],sep=',') )
# use 1 and -1 to indicate direction of up-regulated and down-regulated genes
value <- sapply( 1:nrow(gff_up) , function(i)
paste(gff_up$value[i],gff_down$value[i],sep=',') )
# transform the gene set into matrix, where the row represents the gene,
# the column represents the drug perturbation, and each entry takes values of
# 1 and -1
net1 <- geneSet2Net( term=term_up , geneset=geneset , value=value )
# transform the gene set into sparse matrix, where the row represents the gene,
# the column represents the drug perturbation, and each entry takes values of
# 1 and -1
net2 <- geneSet2sparseMatrix( term=term_up , geneset=geneset , value=value )
tail(net1[,1:30])## Fluorouracil,drug:3639 Resveratrol,drug:3499 Citalopram,drug:3292
## cra 0 0 0
## l7Rn6 0 0 0
## mrpl11 0 0 0
## mrpl24 0 0 0
## mrpl9 0 0 0
## ste2 0 0 0
## Fluorouracil,drug:3638 Ethanol,drug:3475 Resveratrol,drug:3498
## cra 0 0 0
## l7Rn6 0 0 0
## mrpl11 0 0 0
## mrpl24 0 0 0
## mrpl9 0 0 0
## ste2 0 0 0
## Fluorouracil,drug:3637 Resveratrol,drug:3497 Sodium arsenite,drug:3357
## cra 0 0 0
## l7Rn6 0 0 0
## mrpl11 0 0 0
## mrpl24 0 0 0
## mrpl9 0 0 0
## ste2 0 0 0
## Vitamin c,drug:3510 Vitamin c,drug:3511 Perfluorooctanoic acid,drug:3516
## cra 0 0 0
## l7Rn6 0 0 0
## mrpl11 0 0 0
## mrpl24 0 0 0
## mrpl9 0 0 0
## ste2 0 0 0
## Perfluorooctanoic acid,drug:3517 Formaldehyde,drug:3550
## cra 0 0
## l7Rn6 0 0
## mrpl11 0 0
## mrpl24 0 0
## mrpl9 0 0
## ste2 0 0
## Tretinoin,drug:3634 Vitamin e,drug:3515 Gefitinib,drug:3474
## cra 0 0 0
## l7Rn6 0 0 0
## mrpl11 0 0 0
## mrpl24 0 0 0
## mrpl9 0 0 0
## ste2 0 0 0
## Methylprednisolone,drug:3668 Methylprednisolone,drug:3669
## cra 0 0
## l7Rn6 0 0
## mrpl11 0 0
## mrpl24 0 0
## mrpl9 0 0
## ste2 0 0
## Levetiracetam,drug:2671 Rosiglitazone,drug:2672 Alitretinoin,drug:2673
## cra 0 0 0
## l7Rn6 0 0 -1
## mrpl11 0 0 0
## mrpl24 0 0 0
## mrpl9 0 0 0
## ste2 0 0 0
## Tretinoin,drug:3233 Tretinoin,drug:3232 Tretinoin,drug:3231
## cra 0 0 0
## l7Rn6 0 0 0
## mrpl11 0 0 0
## mrpl24 0 0 0
## mrpl9 0 0 0
## ste2 0 0 0
## Pristane,drug:3230 Tretinoin,drug:3237 Hypochlorous acid,drug:3198
## cra 0 0 0
## l7Rn6 0 0 0
## mrpl11 0 0 0
## mrpl24 0 0 0
## mrpl9 0 0 0
## ste2 0 0 0
## Methoxychlor,drug:3235 4-vinylcyclohexene diepoxide,drug:3234
## cra 0 0
## l7Rn6 0 0
## mrpl11 0 0
## mrpl24 0 0
## mrpl9 0 0
## ste2 0 0## 6 x 30 sparse Matrix of class "dgCMatrix"## [[ suppressing 30 column names 'Fluorouracil,drug:3639', 'Resveratrol,drug:3499', 'Citalopram,drug:3292' ... ]]##
## cra . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
## l7Rn6 . . . . . . . . . . . . . . . . . . . . . -1 . . . . . . . .
## mrpl11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
## mrpl24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
## mrpl9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
## ste2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .# the size of sparse matrix is much smaller than the matrix
format( object.size(net1), units = "auto")## [1] "197.6 Mb"## [1] "7.9 Mb"After obtaining the imputed differential gene expression and the weights, we build the weighted linear regression model to investigate the gene set enrichment. Permutation test was used to adjust the p values of the regression coefficients. We repeatedly shuffle the differential gene expression to obtain a global null distribution of no associated gene sets and calculate the empirical p value for each gene set. For the Single Gene Set Erichment Analysis (SGSEA), especially with many gene sets tested, a large number of weighted simple linear regression model would be interrogated. To improve the efficiency, we use weighted Pearson correlation to rank the significance, which uses the same hypothesis statistic with the weighted linear regression model. Furthermore, we expressed it in terms of large matrix inner product, substantially improving the time efficiency.
# take MSigDB.KEGG.Pathway as an example
net <- MSigDB.KEGG.Pathway$net
# intersect the permuted genes with the gene sets of interest
data2 <- orderedIntersect( x = data , by.x = data$gene , by.y = rownames(net) )
net2 <- orderedIntersect( x = net , by.x = rownames(net) , by.y = data$gene )
all( rownames(net2) == as.character(data2$gene) )## [1] TRUE# the SGSEA.res1 uses the weighted simple linear regression model, while
# SGSEA.res2 used the weighted Pearson correlation. The latter one takes
# substantially less time.
system.time( SGSEA.res1 <- permutationSimpleLm( fc=data2$fc , net=net2 ,
weights=data2$weights , num=100 ) )## 0%.....10%.....20%.....30%.....40%.....50%.....60%.....70%.....80%.....90%.....100%.## user system elapsed
## 29.964 0.036 30.003system.time( SGSEA.res2 <- permutationSimpleLmMatrix( fc=data2$fc ,
net=net2 , weights=data2$weights , num=100 ) )## 0%.....10%.....20%.....30%.....40%.....50%.....60%.....70%.....80%.....90%.....100%.## user system elapsed
## 0.157 0.252 0.110## term usedGenes observedCorr
## 9 KEGG_STEROID_BIOSYNTHESIS 13 0.10579471
## 117 KEGG_TIGHT_JUNCTION 81 0.09104426
## 105 KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION 70 0.08248315
## 67 KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 27 -0.07912328
## 29 KEGG_GLUTATHIONE_METABOLISM 36 -0.06984190
## 68 KEGG_DRUG_METABOLISM_CYTOCHROME_P450 23 -0.06442495
## empiricalPval BayesFactor
## 9 0.0002741935 1294.333011
## 117 0.0012956989 286.354702
## 105 0.0027473118 114.517063
## 67 0.0050591398 44.055850
## 29 0.0097365591 6.527533
## 68 0.0152204301 0.000000A gene may function in multiple ways and thus appear multiple times in functional gene sets. In spite of reflecting the crosstalk between gene sets, such overlap may make the results of gene set analysis more difficult to interpret. To address the redundancy existing among gene sets, we build a weighted multiple linear regression model, taking into account all gene sets in one model. The redundancy of one gene set can be adjusted by considering all other gene sets as covariates. To improve the time efficiency, we also use matrix operation to solve the weighted multiple regression model.
# MGSEA.res1 uses the weighted multiple linear regression model
system.time( MGSEA.res1 <- permutationMultipleLm( fc=data2$fc , net=net2 ,
weights=data2$weights , num=1000 ) )## 0%.....10%.....20%.....30%.....40%.....50%.....60%.....70%.....80%.....90%.....100%.## user system elapsed
## 75.391 127.956 51.301# MGSEA.res2 used the matrix solution
system.time( MGSEA.res2 <- permutationMultipleLmMatrix( fc=data2$fc ,
net=net2 , weights=data2$weights , num=1000 ) )## 0%.....10%.....20%.....30%.....40%.....50%.....60%.....70%.....80%.....90%.....100%.## user system elapsed
## 0.917 0.602 0.540## term usedGenes observedTstats
## 9 KEGG_STEROID_BIOSYNTHESIS 13 6.478134
## 105 KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION 70 5.198424
## 8 KEGG_FATTY_ACID_METABOLISM 28 3.778185
## 60 KEGG_RETINOL_METABOLISM 19 -3.554576
## 117 KEGG_TIGHT_JUNCTION 81 3.405676
## 72 KEGG_RIBOSOME 63 3.252726
## empiricalPval BayesFactor
## 9 0.0001672043 1014.23361
## 105 0.0013284946 59.30751
## 8 0.0110166667 0.00000
## 60 0.0164467742 0.00000
## 117 0.0186672043 0.00000
## 72 0.0228983871 0.00000In user’s convenience, we combine the above procedures together into
one function weightedGSEA(). Based on the imputed
differential gene expression, weightedGSEA() checks
multiple classes of gene sets simultaneously and writes out the
enrichment analysis results. Users need to provide the same data with
above, and specify the columns of gene names (geneCol), imputed
differential gene expression (fcCol), and weights (weightCol).
Additionally, users specify the gene sets of interest (geneSet), the
times of permutation (permutationNum) and the directory for saving the
results (outputDir). By default, we only do SGSEA. Users can specify
MGSEAthres to perform MGMEA for those with less than
MGSEAthres gene sets.
# import packages and prepare data as above
library(GIGSEA)
# prepare the dataset
data(heart.metaXcan)
gene = heart.metaXcan$gene_name
fc <- heart.metaXcan$zscore
usedFrac <- heart.metaXcan$n_snps_used / heart.metaXcan$n_snps_in_cov
r2 <- heart.metaXcan$pred_perf_r2
weights <- usedFrac*r2
data <- data.frame(gene,fc,weights)
# run one-step GIGSEA
#weightedGSEA(data, geneCol='gene', fcCol='fc', weightCol= 'weights',
#geneSet=c("MSigDB.KEGG.Pathway","Fantom5.TF","TargetScan.miRNA","GO"),
#permutationNum=10000, outputDir="./GIGSEA" )
#dir("./GIGSEA")